Abstract
Three hundred and seventy-two patients were randomized between 3 regimens of chemotherapy: cyclophosphamide, intermittent melphalan, and melphalan with prednisone, and were followed up to death or for at least 5 years. There was no difference in survival between the treatments, either overall or in any subgroup of patients. Therefore, the choice among these 3 treatments should be guided by the patient's comfort and convenience. The most important prognostic feature at presentation was the quality of renal function. It was possible to define good, intermediate and poor renal-function groups which were highly correlated with prognosis (X2 for trend = 62.6). The haemoglobin level at presentation was strongly correlated with prognosis among patients in the good renal-function group. Among 107 patients who presented with good renal function and with haemoglobin above 100 g/l, the 5-year survival was 43%. Other prognostic features were much less important when account was taken of renal function and haemoglobin level.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 24 print issues and online access
$259.00 per year
only $10.79 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Consortia
Rights and permissions
About this article
Cite this article
Medical Research Council's Working Party on Leukaemia in Adults. Report on the second myelomatosis trial after five years of follow-up.. Br J Cancer 42, 813–822 (1980). https://doi.org/10.1038/bjc.1980.328
Issue Date:
DOI: https://doi.org/10.1038/bjc.1980.328
This article is cited by
-
Autologous stem cell transplantation in myeloma: the St James’s Hospital experience, 1997–2003
Irish Journal of Medical Science (2005)
-
Multiple Myeloma
Clinical Immunotherapeutics (1995)
-
Analyse prognostischer Faktoren beim Plasmozytom
Klinische Wochenschrift (1984)